Table 1.
Characteristics of women with Chlamydia trachomatis infection.
| N = 72 | |
|---|---|
| Age (years) | 24 ± 5 |
| Parity | 1 (0–2) |
| Gestational age of pregnant participantsa | 16 (11–25) |
| Body mass index (BMI) | 29 8 |
| Public health insurance | 47 (65%) |
| Ethnicity | |
| Non-Hispanic, Black/African American | 60 (83%) |
| Hispanic, non-Black | 1 (1%) |
| Less than a high school education | 47 (65%) |
| Age of sexual debut (years) | 16 (15–17) |
| Number of reported lifetime sexual partners | 5 (3–8) |
| History of abnormal cervical cancer screening | 22 (31%) |
| Current tobacco use | 13 (18%) |
| History of a sexually transmitted infection(s) (STI) | 47 (65%) |
| Bacterial vaginosis at enrollment | 25 (35%) |
| An additional STI at enrollment | 12 (17%) |
| Trichomonas vaginalis | 8 (11%) |
| Neisseria gonorrhoeae | 5 (7%) |
| Reported provision of expedited partner therapy | 42 (58%) |
| Days followed until a negative chlamydia NAAT | 12 (7–20) |
| Late submission of chlamydia NAATb | 25 (35%) |
| Lost to follow upc | 13 (18%) |
a
Gestational age of pregnant participants is reported as the weeks of gestation during which participants received initial treatment for chlamydial infection.
b
Late submission of chlamydia NAAT was defined as submission of a NAAT test >10 days following treatment or last study appointment.
c
Lost to follow up was defined as failure to complete the study by returning to submit chlamydia NAATs until a negative result returned within the study period post-treatment. Means are reported with standard deviation (±) and medians are reported with interquartile ranges (IQR).